Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments.
JSON
Liao H, Ji F, Helleday T, Ying S
EMBO Rep. 19 (9) - [2018-09-00; online 2018-08-13]
Timely and faithful duplication of the entire genome depends on completion of replication. Replication forks frequently encounter obstacles that may cause genotoxic fork stalling. Nevertheless, failure to complete replication rarely occurs under normal conditions, which is attributed to an intricate network of proteins that serves to stabilize, repair and restart stalled forks. Indeed, many of the components in this network are encoded by tumour suppressor genes, and their loss of function by mutation or deletion generates genomic instability, a hallmark of cancer. Paradoxically, the same fork-protective network also confers resistance of cancer cells to chemotherapeutic drugs that induce high-level replication stress. Here, we review the mechanisms and major pathways rescuing stalled replication forks, with a focus on fork stabilization preventing fork collapse. A coherent understanding of how cells protect their replication forks will not only provide insight into how cells maintain genome stability, but also unravel potential therapeutic targets for cancers refractory to conventional chemotherapies.
PubMed 30108055
DOI 10.15252/embr.201846263
Crossref 10.15252/embr.201846263
pii: embr.201846263
pmc: PMC6123652